Blog

Seek truth from facts, competitive symbiosis

scroll down

Announcement of Resolutions of the First Extraordinary Shareholders’ Meeting of 2025 of Hunan Zhengqing Pharmaceutical Group Co., Ltd.

Release time:

2025-12-29

Hunan Zhengqing Pharmaceutical Group Co., Ltd.

Announcement of Resolutions Adopted at the First Interim Shareholders’ Meeting of 2025

 

I. Meeting Convening and Attendance Situation

Meeting time: December 29, 2025, 9:30 a.m.

Venue: Conference Room on the 5th Floor, Company No. 7 CaiFu Road, Huaihua High-Tech Development Zone, Hunan Province

Format: In-person

Meeting Convener: Board of Directors

Meeting Chair: Chairman Wu Feichi

The total number of shareholders and shareholder representatives attending this shareholders’ meeting is: 17  Position, holding voting rights 171,450,008 Shares, representing a percentage of the company's total shares 83.93%。

II. Status of Bill Review

This meeting reviewed one motion in total, as follows:

1.《 Regarding the loan from Huaihua Dadi Holding Co., Ltd. to Hunan Zhengqing Pharmaceutical Group Co., Ltd. Exhibition Extension Proposal for Related-Party Transactions (Shareholders related to this proposal) Huaihua Dadi Holding Co., Ltd., Huaihua Mountainous Area Management Co., Ltd., Huaihua Tongyuan Enterprise Management Partnership (Limited Partnership), Huaihua Tongshun Enterprise Management Partnership (Limited Partnership), Wu Feichi, Huang Yuming, and Liu Zhiping abstained from voting.

Voting result: One of the proposals reviewed at this meeting was approved.

  III. Lawyer’s Witnessing Status

This shareholders’ meeting is organized by Hunan Qiyuan Law Firm. Xia Peng, Zhang Xizi The lawyer witnessed and issued a legal opinion stating that the convening and holding procedures of this shareholders’ meeting, the qualifications of the attendees, the voting procedures, and the voting results are all lawful and valid.

 

Hunan Zhengqing Pharmaceutical Group Co., Ltd.

December 29, 2025